ALB
ALBEMARLE CORP
NYSE · Basic Materials · Chemicals - Specialty · US
$110.91
−3.60%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $2.55
- Revenue estimate
- $1.5B
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $3.75
- EPS estimate
- $3.20
- Revenue actual
- $1.7B
- Revenue estimate
- $1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +50.1%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $174
- PT range
- $140 – $225
- Analysts
- 11
7 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $3.20 | $3.75 | Beat 17.19% | $1.7B |
| May 7, 2026 | $1.24 | $2.95 | Beat 137.90% | $1.4B |
| Feb 11, 2026 | -$0.40 | -$0.53 | Miss -32.50% | $1.4B |
| Nov 5, 2025 | -$0.86 | -$0.19 | Beat 77.94% | $1.3B |
| Jul 30, 2025 | -$0.83 | $0.11 | Beat 113.25% | $1.3B |
| Apr 30, 2025 | -$0.62 | -$0.18 | Beat 70.97% | $1.1B |
| Feb 12, 2025 | -$0.60 | -$1.09 | Miss -81.67% | $1.2B |
| Jul 31, 2024 | $0.53 | $0.04 | Miss -92.45% | $1.4B |
| May 1, 2024 | $0.25 | $0.26 | Beat 2.89% | $1.4B |
| Feb 14, 2024 | $0.99 | $1.85 | Beat 86.87% | $2.4B |
| Nov 1, 2023 | $3.99 | $2.74 | Miss -31.33% | $2.3B |
| Aug 2, 2023 | $4.27 | $7.33 | Beat 71.66% | $2.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026